Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH

NCT02484807 · clinicaltrials.gov ↗

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

OTHER: no intervention, only observation of different groups

Sponsor

Heidelberg University